Does RUXOLITINIB Cause Fluid retention? 294 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 294 reports of Fluid retention have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.4% of all adverse event reports for RUXOLITINIB.
294
Reports of Fluid retention with RUXOLITINIB
0.4%
of all RUXOLITINIB reports
30
Deaths
148
Hospitalizations
How Dangerous Is Fluid retention From RUXOLITINIB?
Of the 294 reports, 30 (10.2%) resulted in death, 148 (50.3%) required hospitalization, and 6 (2.0%) were considered life-threatening.
Is Fluid retention Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 294 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Fluid retention?
AMBRISENTAN (3,927)
TREPROSTINIL (3,804)
MACITENTAN (2,861)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (2,233)
SACUBITRIL\VALSARTAN (2,187)
ADALIMUMAB (1,193)
SELEXIPAG (1,044)
FUROSEMIDE (1,020)
LENALIDOMIDE (1,007)
EPOPROSTENOL (929)
Which RUXOLITINIB Alternatives Have Lower Fluid retention Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE